These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10982266

  • 1. Inhibitors in haemophilia: a primer.
    DiMichele DM.
    Haemophilia; 2000 Jul; 6 Suppl 1():38-40. PubMed ID: 10982266
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Switching haemophilia products and inhibitor risk: a United States' perspective.
    Nance D, Rodgers GM.
    Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR, UK Haemophilia Centre Doctors.
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B.
    Dev Biol (Basel); 2003 Jan; 112():55-9. PubMed ID: 12762504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
    Hedner U.
    Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
    [No Abstract] [Full Text] [Related]

  • 9. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
    Mathias M, Khair K, Hann I, Liesner R.
    Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology of inhibitor development in haemophilia A patients treated with virus-inactivated plasma-derived clotting factor concentrates.
    Kreuz W, Escuriola-Ettingshausen C, Martinez-Saguer I, Kaiml M, Kornhuber B.
    Vox Sang; 1999 May; 77 Suppl 1():3-8. PubMed ID: 10529676
    [No Abstract] [Full Text] [Related]

  • 11. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
    Rangarajan S, Jiménez-Yuste V, Santagostino E.
    Haemophilia; 2014 Nov; 20(6):e414-7. PubMed ID: 25333452
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
    Astermark J, Morado M, Rocino A, van den Berg HM, von Depka M, Gringeri A, Mantovani L, Garrido RP, Schiavoni M, Villar A, Windyga J, EHTSB.
    Haemophilia; 2006 Jul; 12(4):363-71. PubMed ID: 16834735
    [Abstract] [Full Text] [Related]

  • 14. Acute Hepatitis E Virus infection in a hemophilic patient with acquired inhibitor during immune tolerance therapy according to modified Bonn-Malmö protocol.
    Schlabe S, van Bremen K, Goldmann G, Oldenburg J, Eis-Hübinger AM, Zeitler H, Spengler U.
    Haemophilia; 2019 Mar; 25(2):e117-e120. PubMed ID: 30694010
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to factor VIII in hemophilia A patients.
    Brackmann HH, Schwaab R, Effenberger W, Hess L, Hanfland P, Oldenburg J.
    Vox Sang; 2000 Mar; 78 Suppl 2():187-90. PubMed ID: 10938950
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The German National Immune Tolerance Registry, 1997 update. Study Group of German Haemophilia Centres.
    Lenk H.
    Vox Sang; 1999 Mar; 77 Suppl 1():28-30. PubMed ID: 10529683
    [No Abstract] [Full Text] [Related]

  • 18. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
    Biss TT, Chan AK, Blanchette VS, Iwenofu LN, McLimont M, Carcao MD, Association of Hemophilia Clinic Directors of Canada (AHCDC), Canadian Association of Nurses in Hemophilia Care (CANHC).
    Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
    [Abstract] [Full Text] [Related]

  • 19. How to manage invasive procedures in children with haemophilia.
    Ljung RC, Knobe K.
    Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
    [Abstract] [Full Text] [Related]

  • 20. Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry.
    Haya S, López MF, Aznar JA, Batlle J, Spanish Immune Tolerance Group.
    Haemophilia; 2001 Mar; 7(2):154-9. PubMed ID: 11260274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.